William H. Carson

12.3k total citations
141 papers, 8.8k citations indexed

About

William H. Carson is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, William H. Carson has authored 141 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Psychiatry and Mental health, 27 papers in Clinical Psychology and 26 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in William H. Carson's work include Schizophrenia research and treatment (92 papers), Bipolar Disorder and Treatment (50 papers) and Treatment of Major Depression (23 papers). William H. Carson is often cited by papers focused on Schizophrenia research and treatment (92 papers), Bipolar Disorder and Treatment (50 papers) and Treatment of Major Depression (23 papers). William H. Carson collaborates with scholars based in United States, Germany and Belgium. William H. Carson's co-authors include Robert D. McQuade, Ronald N. Marcus, Raymond Sanchez, Г. Ингенито, Anutosh Ranjan Saha, Mirza W. Ali, John M. Kane, Elyse Stock, Randall Owen and George Manos and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

William H. Carson

139 papers receiving 8.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
William H. Carson 7.0k 1.9k 1.5k 1.1k 883 141 8.8k
Robert D. McQuade 8.0k 1.1× 3.0k 1.6× 1.8k 1.2× 1.6k 1.4× 1.1k 1.3× 199 11.4k
Ronald N. Marcus 5.2k 0.7× 1.4k 0.7× 1.2k 0.8× 1.1k 1.0× 563 0.6× 87 6.5k
Miquel Bernardo 5.5k 0.8× 994 0.5× 1.5k 1.0× 1.7k 1.5× 370 0.4× 406 8.8k
Gary D. Tollefson 8.4k 1.2× 3.8k 2.0× 1.9k 1.3× 872 0.8× 581 0.7× 163 12.3k
Joanne B. Severe 7.5k 1.1× 903 0.5× 3.6k 2.4× 1.2k 1.1× 603 0.7× 39 9.9k
Charles M. Beasley 5.8k 0.8× 2.5k 1.3× 1.4k 1.0× 398 0.3× 397 0.4× 145 8.1k
Nina R. Schooler 7.2k 1.0× 910 0.5× 2.7k 1.8× 1.2k 1.1× 440 0.5× 208 9.3k
Bruce J. Kinon 5.0k 0.7× 845 0.4× 1.1k 0.8× 882 0.8× 291 0.3× 153 7.4k
Ana González‐Pinto 6.7k 1.0× 1.1k 0.6× 2.3k 1.6× 1.1k 1.0× 442 0.5× 376 10.0k
Michael Gitlin 5.5k 0.8× 1.1k 0.6× 2.3k 1.5× 731 0.6× 557 0.6× 151 8.3k

Countries citing papers authored by William H. Carson

Since Specialization
Citations

This map shows the geographic impact of William H. Carson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Carson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Carson more than expected).

Fields of papers citing papers by William H. Carson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Carson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Carson. The network helps show where William H. Carson may publish in the future.

Co-authorship network of co-authors of William H. Carson

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Carson. A scholar is included among the top collaborators of William H. Carson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Carson. William H. Carson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Joseph H., Saket Jain, Kayla J. Wolf, et al.. (2023). Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations. Journal of Clinical Investigation. 134(3). 13 indexed citations
2.
Calabrese, Joseph R., Raymond Sanchez, Na Jin, et al.. (2018). The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study. Journal of Affective Disorders. 241. 425–432. 15 indexed citations
3.
Sallee, Floyd R., Eva Kohegyi, Joan Zhao, et al.. (2017). Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 27(9). 771–781. 78 indexed citations
4.
Calabrese, Joseph R., Raymond Sanchez, Na Jin, et al.. (2017). Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder. The Journal of Clinical Psychiatry. 78(3). 324–331. 72 indexed citations
5.
Fleischhacker, W. Wolfgang, Mary Hobart, John Ouyang, et al.. (2016). Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study. The International Journal of Neuropsychopharmacology. 20(1). pyw076–pyw076. 67 indexed citations
6.
Thase, Michael E., James M. Youakim, Aleksandar Skuban, et al.. (2015). Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder. The Journal of Clinical Psychiatry. 76(9). 1224–1231. 145 indexed citations
7.
Thase, Michael E., James M. Youakim, Aleksandar Skuban, et al.. (2015). Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants. The Journal of Clinical Psychiatry. 76(9). 1232–1240. 136 indexed citations
8.
Kane, John M., Raymond Sanchez, Ross A. Baker, et al.. (2015). Patient-Centered Outcomes with Aripiprazole Once-Monthly for Maintenance Treatment in Patients with Schizophrenia: Results From Two Multicenter, Randomized, Double-Blind Studies. Clinical Schizophrenia & Related Psychoses. 9(2). 79–87. 15 indexed citations
9.
Mallikaarjun, Suresh, John M. Kane, Patricia Bricmont, et al.. (2013). Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study. Schizophrenia Research. 150(1). 281–288. 76 indexed citations
10.
Youngstrom, Eric A., Joan Zhao, Raymond Mankoski, et al.. (2013). Clinical Significance of Treatment Effects with Aripiprazole versus Placebo in a Study of Manic or Mixed Episodes Associated with Pediatric Bipolar I Disorder. Journal of Child and Adolescent Psychopharmacology. 23(2). 72–79. 21 indexed citations
11.
Fleischhacker, W. Wolfgang, Pamela Perry, Raymond Sanchez, et al.. (2013). Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia. Value in Health. 16(7). A550–A550. 1 indexed citations
12.
Kane, John M., Raymond Sanchez, Pamela Perry, et al.. (2012). Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia. The Journal of Clinical Psychiatry. 73(5). 617–624. 167 indexed citations
13.
Mankoski, Raymond, et al.. (2011). Young Mania Rating Scale Line Item Analysis in Pediatric Subjects with Bipolar I Disorder Treated with Aripiprazole in a Short-Term, Double-Blind, Randomized Study. Journal of Child and Adolescent Psychopharmacology. 21(4). 359–364. 9 indexed citations
14.
Marcus, Ronald N., Randall Owen, George Manos, et al.. (2011). Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6–17 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 21(3). 229–236. 57 indexed citations
15.
Robb, Adelaide S., William H. Carson, Margaretta Nyilas, et al.. (2010). Changes in Positive and Negative Syndrome Scale–Derived Hostility Factor in Adolescents with Schizophrenia Treated with Aripiprazole: Post Hoc Analysis of Randomized Clinical Trial Data. Journal of Child and Adolescent Psychopharmacology. 20(1). 33–38. 12 indexed citations
16.
Marcus, Ronald N., Robert D. McQuade, William H. Carson, et al.. (2008). The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder. Journal of Clinical Psychopharmacology. 28(2). 156–165. 272 indexed citations
17.
Thase, Michael E., Alain M. Jonas, Arif Khan, et al.. (2008). Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression. Journal of Clinical Psychopharmacology. 28(1). 13–20. 185 indexed citations
18.
Newcomer, John W., Ronald N. Marcus, Christopher D. Breder, et al.. (2008). A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine. The Journal of Clinical Psychiatry. 69(7). 1046–1056. 96 indexed citations
19.
Findling, Robert L., J Blumer, Ralph E. Kauffman, et al.. (2004). Pharmacokinetic effects of aripiprazole in children and adolescents with conduct disorder. The International Journal of Neuropsychopharmacology. 7. 10 indexed citations
20.
Carson, William H., et al.. (1998). Ethical approach in contemporary psychiatry: a pragmatic approach in a Psychiatry Access Center. General Hospital Psychiatry. 20(4). 231–234. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026